87 FR 44 pgs. 12710-12711 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA-CE22-002, Grants To Support New Investigators in Conducting Research Related To Preventing Interpersonal Violence Impacting Children and Youth; Amended Notice of Meeting
Type: NOTICEVolume: 87Number: 44Pages: 12710 - 12711
Pages: 12710, 12711FR document: [FR Doc. 2022-04680 Filed 3-4-22; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-CE22-002, Grants To Support New Investigators in Conducting Research Related To Preventing Interpersonal Violence Impacting Children and Youth; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)- RFA-CE22-002, Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth, March 8-9, 2022, 8:30 a.m., EDT-5:30 p.m., EDT, Web Conference, in the original FRN. The meeting was published in the Federal Register on January 5, 2022, Volume 87, Number 3, page 460.
The meeting is being amended to change the meeting date and should read as follows:
[top] RFA-CE22-002, Grants to Support New Investigators in Conducting Research Related to Preventing
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Aisha L. Wilkes, M.P.H., Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341, Telephone (404) 639-6473, AWilkes@cdc.gov.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-04680 Filed 3-4-22; 8:45 am]
BILLING CODE 4163-18-P